Showing results (151-160 of 378) with videos related to

Sort By:
Pageof 38
Bone Marrow Transplantation|December 10, 2013
Value of novel agents and intensive therapy for patients with multiple myelomaR Alexanian, M Wang, K Delasalle, et al.
ESMO Open|September 6, 2021
Immune checkpoint inhibitor administration during pregnancy: a case seriesA Andrikopoulou, A M Korakiti, K Apostolidou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Waldenström's macroglobulinemia: clinical features, complications, and managementM A Dimopoulos, P Panayiotidis, L A Moulopoulos, et al.
Restorative Neurology and Neuroscience|January 7, 2011
Survival of neurally induced mesenchymal cells may determine degree of motor recovery in injured spinal cord ratsArshak R Alexanian, Wai-Meng Kwok, Danijel Pravdic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
Carfilzomib and pomalidomide in patients with relapsed and/or refractory multiple myeloma with baseline risk factorsM A Dimopoulos, P Sonneveld, D Siegel, et al.
Urology|June 3, 1998
Static cytometry and neural networks in the discrimination of lower urinary system lesionsD Pantazopoulos, P Karakitsos, A Pouliakis, et al.
Leukemia & Lymphoma|July 12, 2003
Bone marrow angiogenesis and progression in multiple myeloma: clinical significance and therapeutic approachV Eleutherakis-Papaiakovou, M Karali, I Kokkonouzis, et al.
Bone Marrow Transplantation|July 5, 2001
Impact of complete remission with intensive therapy in patients with responsive multiple myelomaR Alexanian, D Weber, S Giralt, et al.
American Journal of Hematology|September 1, 1988
Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemiaJ R Quesada, R Alexanian, R Kurzrock, et al.
Pageof 38